ADHD Trial, Recruiting (NCT05700539)

ADHD Trial, Recruiting NCT05700539 Sponsor: Karolinska Institutet Condition: ADHD

Printed from Voxsanity (voxsanity.com.au) — NCT05700539 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Adhd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are over 18 years old
People who can read and write in Swedish
People who have access to a computer, tablet, or smartphone with an internet connection
People who have previously been diagnosed with ADHD
People who are currently studying at a university or college in Sweden, or who are working at least half of a standard full-time workload

Who may not be able to join:

People whose symptoms of depression are rated as severe, or who show signs of suicidal thinking, based on a standard questionnaire used by the trial site (the PHQ-9 screening tool)
People who have started taking a new psychiatric medication, or changed an existing one, within the last three months
People who have another psychiatric condition that requires more specialised care — such as substance abuse disorder, anorexia nervosa, bipolar disorder, psychotic symptoms, or schizophrenia — as determined through a structured assessment carried out by the trial site

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: David Forsström, PhD, Uppsala University

Phone: +46(0)736937948

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05700539

Sponsor: Karolinska Institutet

Phase: Not Applicable

Status: Recruiting

Condition: ADHD

Trial contact: +46(0)736937948

More information: https://clinicaltrials.gov/study/NCT05700539

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are over 18 years old
People who can read and write in Swedish
People who have access to a computer, tablet, or smartphone with an internet connection
People who have previously been diagnosed with ADHD
People who are currently studying at a university or college in Sweden, or who are working at least half of a standard full-time workload

Who may not be able to join:

People whose symptoms of depression are rated as severe, or who show signs of suicidal thinking, based on a standard questionnaire used by the trial site (the PHQ-9 screening tool)
People who have started taking a new psychiatric medication, or changed an existing one, within the last three months
People who have another psychiatric condition that requires more specialised care — such as substance abuse disorder, anorexia nervosa, bipolar disorder, psychotic symptoms, or schizophrenia — as determined through a structured assessment carried out by the trial site

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Karolinska Institutet

Registry

ClinicalTrials.gov

Start date

25 January 2023

Est. completion

1 November 2025

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Adult Attention-deficit/hyperactivity disorder Quality-of-Life scale (AAQoL); Adult Attention-deficit/hyperactivity disorder Quality-of-Life scale (AAQoL); Adult ADHD Self-Report Scale-V1.1 (ASRS-V1.1) Symptoms Checklist (ASRS); Adult ADHD Self-Report Scale-V1.1 (ASRS-V1.1) Symptoms Checklist (ASRS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov